Can You Take Citalopram with Venlafaxine?
A plain-English look at the moderate interaction between Citalopram (Celapram) and Venlafaxine (Efexor-XR) — what it means, why it happens, and what to talk to your doctor or pharmacist about.
Combining Citalopram (Celapram) with Venlafaxine (Efexor-XR) is a moderate interaction requiring caution and monitoring. Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
Not sure about your specific combination? Check it in the Drug Interaction Checker →
Key Takeaways
- Interaction severity: Moderate
- Risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.
- Mechanism: Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
- Citalopram: S4 in Australia, low risk
- Venlafaxine: S4 in Australia, low risk
- Claims action: Monitor and document. Request clinical justification if combination is ongoing.
Citalopram vs Venlafaxine at a Glance
| Property | Citalopram | Venlafaxine |
|---|---|---|
| Brand names | Celapram, Talam, CITALOPRAM-WGR | Efexor-XR, Venlafaxine generichealth XR, APO-Venlafaxine XR |
| Drug class | opioid | antidepressant |
| Risk level | low | low |
| TGA Schedule (AU) | S4 | S4 |
Why Is This Combination Dangerous?
Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a moderate drug interaction requiring monitoring and clinical review.
United Kingdom NICE / MHRA / FPM
NICE guidelines advise against combining multiple serotonergic medications due to the risk of serotonin syndrome. For personal injury claims, antidepressant prescribing should be reviewed for injury relatedness and appropriateness.
United States FDA / CDC / State WC
The FDA has issued Drug Safety Communications about the risk of serotonin syndrome with concurrent use of serotonergic medications. Workers compensation nurse case managers should flag this combination for prescriber review.
What Claims Professionals Should Do
- Document the combination in the claim file with a note on interaction risk
- Request clinical justification from the prescriber at the next review
- Monitor for adverse effects including excessive sedation, falls, and cognitive impairment
- Assess injury relatedness of both medications to the compensable condition
- Review at next claim assessment and consider whether the combination is still clinically appropriate
Clinical reference
A clinical summary of Citalopram and Venlafaxine drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.
Severity assessment
Major. The combination significantly increases the risk of serotonin syndrome, a potentially life-threatening condition, and also elevates the risk of serious bleeding.
Mechanism (plain English)
Both citalopram, a selective serotonin reuptake inhibitor (SSRI), and venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), work by increasing the levels of serotonin in the brain. When taken together, this can lead to an excessive accumulation of serotonin, causing a condition known as serotonin syndrome. Additionally, both medications can interfere with the normal function of platelets, which are crucial for blood clotting. This antiplatelet effect, when combined, can increase the likelihood of bleeding, especially in the stomach or intestines. Both drugs can also contribute to low sodium levels in the blood (hyponatremia).
Evidence level
Regulator-flagged. Regulatory bodies such as the FDA and NICE/BNF explicitly warn about the increased risks of serotonin syndrome and bleeding when these types of antidepressants are co-administered [1, 2, 3, 4].
Top regulator advisories (cite verbatim or close paraphrase)
- TGA (Australia): No specific public advisory for the citalopram + venlafaxine pair was found. However, the TGA advises that
Sources used in this brief (6)
- https://www.drugs.com/drug-interactions/citalopram-with-venlafaxine-679-0-2296-0.html
- https://bnf.nice.org.uk/interactions/citalopram/
- https://bnf.nice.org.uk/interactions/venlafaxine/
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020699s112lbl.pdf
- https://www.tga.gov.au/sites/default/files/foi-014-1415-09.pdf
- https://www.ema.europa.eu/en/documents/referral/efexor-article-30-referral-annex-i-ii-iii_en.pdf
Check this medication against your full medication list
Check all interactions for Citalopram and Venlafaxine across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.